Financial Performance - Revenue for the year ended December 31, 2024, was RM 96,990,000, representing a 3.4% increase from RM 93,763,000 in 2023[3] - Gross profit increased by 6.2% to RM 24,332,000 compared to RM 22,907,000 in the previous year[3] - Loss before tax significantly increased to RM (18,541,000), a 1,165.6% rise from RM (1,465,000) in 2023[3] - Loss attributable to equity holders of the Company for the year was RM (21,430,000), up 404.4% from RM (4,249,000) in 2023[3] - Total assets surged by 200.8% to RM 311,662,000 from RM 103,620,000 in 2023[3] - Total equity attributable to equity holders of the Company increased by 257.6% to RM 290,485,000 compared to RM 81,222,000 in 2023[3] - The Group recorded a net loss attributable to equity holders of approximately RM21.4 million for the year ended December 31, 2024, compared to a net loss of RM4.2 million for the previous year, primarily due to a goodwill impairment loss of RM23.3 million[22] - The company's loss for the year amounted to approximately RM21.1 million in 2024, compared to a loss of RM3.4 million in 2023, primarily due to the goodwill impairment loss[81] Revenue Streams - Revenue from outsourced document management services decreased by approximately RM6.4 million or 8.6% from RM73.7 million in 2023 to RM67.3 million in 2024, accounting for 69.4% of total revenue[51] - Revenue from outsourced insurance risk analysis and marketing services increased to approximately RM17.3 million in 2024, representing 17.9% of total revenue, up from RM13.4 million or 14.3% in 2023[56] - Revenue from enterprise software solutions increased by approximately RM1.1 million or 20.2% from RM5.6 million in 2023 to RM6.7 million in 2024, representing 6.9% of total revenue[58] - Revenue from the distribution and sales of medical equipment and pharmaceutical products was approximately RM3.6 million in 2024, up from RM1.2 million in 2023, representing 3.7% of total revenue[60] - Revenue from internet hospital and brick-and-mortar clinical services amounted to approximately RM2.1 million in 2024, representing 2.1% of total revenue[64] Acquisitions and Expansion - The acquisition of 100% of Sun Join on January 26, 2024, enables the Company to offer one-stop insurance and healthcare services[16] - The acquisition of 100% of Shengji's issued shares on January 26, 2024, allows the Group to offer a one-stop insurance and healthcare service to an expanded customer base in China[19] - The company completed the acquisition of 100% of the issued shares of Sun Join for a total consideration of HK474,251,497onJanuary26,2024,makingSunJoinanindirectwholly−ownedsubsidiary[122]CostManagementandProfitability−CostofsalesincreasedbyapproximatelyRM1.8millionor2.566.2 million[141] - A portion of the net proceeds, 76.7% or HK$56.5 million, is designated for acquiring and converting an existing building into a Data Centre and upgrading IT infrastructure[141] - The company will continue to observe business environments and trends to evaluate the use of net proceeds for the best interests of the company[143]